Ella Evron

4.5k total citations
65 papers, 3.5k citations indexed

About

Ella Evron is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ella Evron has authored 65 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 26 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Ella Evron's work include BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (13 papers) and Epigenetics and DNA Methylation (12 papers). Ella Evron is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (13 papers) and Epigenetics and DNA Methylation (12 papers). Ella Evron collaborates with scholars based in Israel, United States and Belgium. Ella Evron's co-authors include Saraswati Sukumar, Jeffrey R. Marks, Christopher B. Umbricht, Venu Raman, Anne Ferguson, Dorian Korz, Edward Gabrielson, Elizabeth Garrett, Elizabeth M. Jaffee and David Reisman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ella Evron

64 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ella Evron 2.4k 928 850 510 330 65 3.5k
Yuriko Mori 2.1k 0.9× 668 0.7× 1.1k 1.3× 307 0.6× 422 1.3× 63 3.2k
Petra van der Groep 1.9k 0.8× 1.2k 1.3× 1.7k 2.0× 549 1.1× 488 1.5× 67 3.7k
Zhe Jin 1.8k 0.7× 308 0.3× 924 1.1× 163 0.3× 340 1.0× 90 2.6k
In Ah Kim 1.1k 0.4× 987 1.1× 874 1.0× 114 0.2× 757 2.3× 162 3.0k
Karin D. Berg 931 0.4× 730 0.8× 456 0.5× 94 0.2× 232 0.7× 29 2.2k
Maxine Tran 1.6k 0.7× 402 0.4× 1.4k 1.7× 358 0.7× 851 2.6× 83 2.8k
Beatrice Malmer 713 0.3× 460 0.5× 375 0.4× 190 0.4× 424 1.3× 42 2.1k
Volker Fendrich 1.4k 0.6× 2.1k 2.3× 515 0.6× 226 0.4× 230 0.7× 69 3.2k
Holger Moch 924 0.4× 830 0.9× 478 0.6× 212 0.4× 469 1.4× 48 2.2k
Hilmi Özçelik 2.3k 0.9× 1.2k 1.3× 758 0.9× 1.1k 2.1× 347 1.1× 79 3.6k

Countries citing papers authored by Ella Evron

Since Specialization
Citations

This map shows the geographic impact of Ella Evron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Evron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Evron more than expected).

Fields of papers citing papers by Ella Evron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella Evron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Evron. The network helps show where Ella Evron may publish in the future.

Co-authorship network of co-authors of Ella Evron

This figure shows the co-authorship network connecting the top 25 collaborators of Ella Evron. A scholar is included among the top collaborators of Ella Evron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Evron. Ella Evron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shachar, Shlomit Strulov, Michelle Leviov, Rinat Yerushalmi, et al.. (2023). Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry. npj Breast Cancer. 9(1). 79–79. 1 indexed citations
2.
Leviov, Michelle, Iryna Kuchuk, Shani Paluch–Shimon, et al.. (2023). Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study. npj Breast Cancer. 9(1). 49–49.
3.
Leviov, Michelle, Iryna Kuchuk, Shani Paluch–Shimon, et al.. (2022). 149P Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data. Annals of Oncology. 33. S607–S608. 1 indexed citations
4.
Avraham, Ayelet, Soonweng Cho, Avishay Sella, et al.. (2020). Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells. Cancers. 12(9). 2367–2367. 3 indexed citations
5.
Denys, Hannelore, Marc Martens, Randal D’hondt, et al.. (2020). Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer. Breast Cancer Research and Treatment. 181(1). 97–105. 26 indexed citations
6.
Evron, Ella, Hadassah Goldberg, Merav Ben‐David, & Benjamin W. Corn. (2019). Participation in a Novel Trial Assessing Prophylactic Breast Irradiation: The Importance of Input From the Radiation Oncologist. International Journal of Radiation Oncology*Biology*Physics. 105(4). 792–794. 1 indexed citations
7.
Paluch–Shimon, Shani & Ella Evron. (2019). Targeting DNA repair in breast cancer. The Breast. 47. 33–42. 12 indexed citations
8.
9.
Safra, Tamar, Bella Kaufman, Luna Kadouri, et al.. (2017). Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial. Clinical Breast Cancer. 18(2). e197–e203. 11 indexed citations
10.
Livoff, Alejandro, et al.. (2017). Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications. European Journal of Surgical Oncology. 43(8). 1415–1420. 13 indexed citations
11.
Netanely, Dvir, Ayelet Avraham, Adit Ben‐Baruch, Ella Evron, & Ron Shamir. (2016). Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups. Breast Cancer Research. 18(1). 117–117. 61 indexed citations
12.
Rubinek, Tamar, Shikha Bose, Ayelet Avraham, et al.. (2011). Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Research and Treatment. 133(2). 649–657. 88 indexed citations
13.
Avraham, Ayelet, Judith Sandbank, Nirit Yarom, et al.. (2010). A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues. Epigenetics. 5(1). 41–46. 13 indexed citations
14.
Yarom, Nirit, et al.. (2009). Epistaxis during Treatment with Paclitaxel. Basic & Clinical Pharmacology & Toxicology. 104(3). 259–261. 1 indexed citations
15.
Paluch–Shimon, Shani, Ido Wolf, Hadassah Goldberg, et al.. (2008). High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer. Acta Oncologica. 47(8). 1564–1569. 11 indexed citations
16.
Kominsky, Scott L., Pedram Argani, Dorian Korz, et al.. (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22(13). 2021–2033. 372 indexed citations
17.
Evron, Ella, William C. Dooley, Christopher B. Umbricht, et al.. (2001). Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. The Lancet. 357(9265). 1335–1336. 270 indexed citations
18.
Cairns, Paul, Ella Evron, Kenji Okami, et al.. (1998). Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene. 16(24). 3215–3218. 146 indexed citations
19.
Malnick, Stephen, et al.. (1997). HCV Hepatitis Associated with Anticardiolipin Antibody and a Cerebrovascular Accident. Journal of Clinical Gastroenterology. 24(1). 40–42. 28 indexed citations
20.
Goland, Sorel, et al.. (1994). Acute Renal Failure Complicating Organophosphate Intoxication. Renal Failure. 16(3). 415–417. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuriko Mori Breakdown of academic impact, for papers by Petra van der Groep Breakdown of academic impact, for papers by Zhe Jin Breakdown of academic impact, for papers by In Ah Kim Breakdown of academic impact, for papers by Karin D. Berg Breakdown of academic impact, for papers by Maxine Tran Breakdown of academic impact, for papers by Beatrice Malmer Breakdown of academic impact, for papers by Volker Fendrich Breakdown of academic impact, for papers by Holger Moch Breakdown of academic impact, for papers by Hilmi Özçelik
Rankless by CCL
2026